Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chel Hun Choi

Showing results (1-10 of 309) with videos related to

Pageof 31
Sort By:
Obstetrics & Gynecology Science|May 31, 2024
Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomyJihye Kim, Chel Hun Choi
Gland Surgery|July 17, 2024
Feasibility of articulating laparoscopic instrument use in laparoscopic adnexectomy: a multicenter prospective observational studyJun-Hyeong Seo, Chel-Hun Choi, Yoo-Young Lee
The Journal of Obstetrics and Gynaecology Research|August 5, 2025
Clinical characteristics and survival outcome of vulvar cancer in South Korea: A nationwide study from the Cancer Public Library DatabaseChel Hun Choi, Ha Kyun Chang, Gi Hwan Bae, et al.
European Radiology|April 14, 2019
Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapyKyo-Won Gu, Chan Kyo Kim, Chel Hun Choi, et al.
Future Oncology (London, England)|June 28, 2024
OPERA: a phase II trial of oregovomab plus non-platinum chemotherapy in PARP inhibitor/platinum-resistant ovarian cancerJunsik Park, Hyun Woong Cho, Myong Cheol Lim, et al.
Journal of Translational Medicine|May 8, 2016
Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patientsChel Hun Choi, Joon-Yong Chung, Jae-Hoon Kim, et al.
Gynecologic Oncology|March 7, 2021
Metabolic syndrome and persistent cervical human papillomavirus infectionJieun Lee, Hye Seung Kim, Kyunga Kim, et al.
Gynecologic Oncology|March 23, 2024
Treatment outcomes according to various progestin treatment strategies in patients with atypical hyperplasia/endometrial intraepithelial neoplasia - Multicenter retrospective study (KGOG2033)Nam Kyeong Kim, Chel Hun Choi, Seok Ju Seong, et al.
Journal of Gynecologic Oncology|March 16, 2026
Cervical neuroendocrine carcinoma with non-neuroendocrine components has a poorer prognosis than pure neuroendocrine carcinomaSun Min Park, Chel Hun Choi, Kidong Kim, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 10, 2016
The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysisTaejong Song, Chel Hun Choi, Mi Kyoung Kim, et al.
Pageof 31

Showing results (1-10 of 309) with videos related to

Sort By:
Pageof 31
Obstetrics & Gynecology Science|May 31, 2024
Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomyJihye Kim, Chel Hun Choi
Gland Surgery|July 17, 2024
Feasibility of articulating laparoscopic instrument use in laparoscopic adnexectomy: a multicenter prospective observational studyJun-Hyeong Seo, Chel-Hun Choi, Yoo-Young Lee
The Journal of Obstetrics and Gynaecology Research|August 5, 2025
Clinical characteristics and survival outcome of vulvar cancer in South Korea: A nationwide study from the Cancer Public Library DatabaseChel Hun Choi, Ha Kyun Chang, Gi Hwan Bae, et al.
European Radiology|April 14, 2019
Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapyKyo-Won Gu, Chan Kyo Kim, Chel Hun Choi, et al.
Future Oncology (London, England)|June 28, 2024
OPERA: a phase II trial of oregovomab plus non-platinum chemotherapy in PARP inhibitor/platinum-resistant ovarian cancerJunsik Park, Hyun Woong Cho, Myong Cheol Lim, et al.
Journal of Translational Medicine|May 8, 2016
Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patientsChel Hun Choi, Joon-Yong Chung, Jae-Hoon Kim, et al.
Gynecologic Oncology|March 7, 2021
Metabolic syndrome and persistent cervical human papillomavirus infectionJieun Lee, Hye Seung Kim, Kyunga Kim, et al.
Gynecologic Oncology|March 23, 2024
Treatment outcomes according to various progestin treatment strategies in patients with atypical hyperplasia/endometrial intraepithelial neoplasia - Multicenter retrospective study (KGOG2033)Nam Kyeong Kim, Chel Hun Choi, Seok Ju Seong, et al.
Journal of Gynecologic Oncology|March 16, 2026
Cervical neuroendocrine carcinoma with non-neuroendocrine components has a poorer prognosis than pure neuroendocrine carcinomaSun Min Park, Chel Hun Choi, Kidong Kim, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 10, 2016
The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysisTaejong Song, Chel Hun Choi, Mi Kyoung Kim, et al.
Pageof 31